Don't have an account?
doses currently produced globally every year1
more iodinated contrast media doses to be delivered annually by 20251
accredited contrast media production facilities globally
invested over the last decade to increase capacity2
GE HealthCare has a distinguished history of contrast media development, offering a comprehensive product range across modalities, with a range of concentrations and innovative packaging choices.
Beyond the scan
Securing future supply of contrast media.
Active Pharmaceutical Ingredients investment
$80 million invested to expand production at our Lindesnes, Norway API facility.
Recycling iodine across the globe
GE HealthCare iodine-recycling program is expanding to help hospitals keep contrast media in the circular economy.
Contrast media production investment
Opening of new $32M manufacturing line in Cork to increase contrast media supply.
1. GE HealthCare Data on File: Planned Investment; 2022
2. GE HealthCare Data on File: Contrast Media Demand; 2022
3. Dhaliwal et al. A life cycle assessment of packaging options for contrast media delivery: comparing polymer bottle vs. glass bottle. Int J Life Cycle Assess. 2014; 19: 1965-73.
4. GE HealthCare Data on File: Iodine-Recycling Program; 2022